SELECT-3: a phase I study of selumetinib in combination with platinum doublet chemotherapy for advanced NSCLC in the first-line setting.
Dean, Emma J Steele, N Arkenau, H Blackhall, Fiona H Haris, N Lindsay, C Rafii, S. Califano, Raffaele Plummer, R Voskoboynik, M
Dean, Emma J
Steele, N
Arkenau, H
Blackhall, Fiona H
Haris, N
Lindsay, C
Rafii, S.
Califano, Raffaele
Plummer, R
Voskoboynik, M
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016-10-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
SELECT-3: a phase I study of selumetinib in combination with platinum doublet chemotherapy for advanced NSCLC in the first-line setting. 2016, 27(suppl 6):1269P Annals of Oncology